Search

everythinglearnresearchcommunity

for

Search:↓

The protein folliculin, involved in a rare disease, works with another protein to control how cells stick together and their organization, and changes in this interaction can lead to disease symptoms.

Targeted therapy with Ustekinumab significantly improved a skin condition called ILVEN, which is caused by mutations in the CARD14 gene.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

A new therapy for a skin blistering condition has not been developed yet.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

Folliculin deficiency causes problems with cell division and positioning due to disrupted RhoA signaling and interaction with p0071.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

BMPR1a-ECD reduces wrinkles much more effectively than retinoic acid.

A KLK5 inhibitor effectively improved skin symptoms in a mouse model of Netherton Syndrome.

Flavin prevents cataracts in young rats.

50-mg ritlecitinib capsules are bioequivalent to 100-mg capsules.

Mutations in the KLHL24 gene cause skin blistering in epidermolysis bullosa simplex.

BRL 7660, once studied for male contraception, showed promise as an acne treatment but was not developed further due to competing drugs.

The new drug delivery system improves bicalutamide skin retention for better treatment of hair loss.

Baricitinib was effective in regrowing eyebrow and eyelash hair in patients with severe alopecia areata.

A new mutation in the PLEC gene causes a rare condition with skin blistering, muscle weakness, and hair loss.

Newly designed proteins can effectively degrade specific proteins in cells, offering a potential new therapy method.

ATR12-351 ointment safely delivers LEKTI protein to the skin, reducing enzyme activity in Netherton syndrome.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

Sciellin is a protein that helps form protective layers in skin, hair, and nails.

Progerin affects cell shape but not hair or skin in mice.

Involucrin is a useful marker for keratinocyte differentiation in mice.

Brimonidine is effective for reducing facial redness in skin conditions and has potential for broader dermatological uses.

BIVV009 is a safe treatment for bullous pemphigoid that reduces C3 deposition without harmful side effects.

Basonuclin may help control ribosomal RNA gene activity in skin cells.

Vitexin Compound 1 may help reduce skin aging caused by UVA light.

Baicalin may help treat severe drug-induced skin reactions.